2025 ISAKOS Congress in Munich, Germany

ISAKOS 2025 Congress Faculty

 

Yuji Uchio, MD, PhD

Department of Orthopaedic Surgery, Shimane University
Izumo, Shimane JAPAN

I. Qualifications: 1986 M.D. Shimane Medical University, Japan 1995 Ph.D. Shimane Medical University, Graduate School, Japan 1993 Medical Specialist Japanese Orthopaedic Association, Orthopaedic Surgeon 1995 Sports medicine Board certified member of Japanese Orthopaedic Association 　　 　　1998 Research fellow Leeds University, Rheumatology, Rehabilitation Research Unit, UK. 　　2003 Hand Surgery Japanese Society for Surgery of the Hand 　　2005 Rheumatology Board certified member of Japanese Orthopaedic Association 　　2008 Rehabilitation Board certified member of Japanese Orthopaedic Association II. Positions held: 2002 Professor and Chairman Department of Orthopaedic Surgery, Shimane Medical University 2003- Professor and Chairman Department of Orthopaedic Surgery, Shimane University, School of Medicine 2009-2011 　　Associate Dean Shimane University, School of Medicine 2013-2015 　　Associate Dean Shimane University, School of Medicine 2017-2019 　　Councilor Shimane University 　　 2021- Dean of Medicine Shimane University, School of Medicine
https://www.med.shimane-u.ac.jp/orthop/

Tue 06/10
14:30 - 14:35 		Room 13a Afternoon Scientific Session I
Paper
The Safety And Effectiveness Of A Synthetic Type I/Iii Collagen Membrane In Covering Matrix-Associated Autologous Chondrocyte Implantation Compared To A Periosteum For Large Cartilage Defects Of The Knee Joints: A Real-World Data Analysis In Japan
Presenting Author

Disclosures

Speaker for J-TEC, Kaken, Seikagaku-kougyou, Daiichi-Sankyo, Yansen, Takeda, Teiji, Ono, Ono
Paid Consultant for J-TEC
Support received from Mochida
Financial Support received from Astellas, Chugai, Hisamitsu, Kaken, Nipponn Zoki, Seikagaku, Pfizer Japan, and Teijin., Stryker
Editorial or Governing board of Journal Orthopaedic Science
Board of Directors member for Japanese Orthopaedic Society of Knee, Arthroscopy, and Spotrs Medicine

All relevant financial disclosures have been mitigated.

View All Global Link Presentations

↑